体外受精の世界市場:器具別(使い捨てデバイス、培養液、資本設備)、プロシージャタイプ別、最終用途別、地域別

◆英語タイトル:In-Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media, Capital Equipment), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY054
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月17日
◆ページ数:139
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、体外受精の世界市場について調査・分析し、調査目的、エグゼクティブサマリー、市場要因・動向・範囲、器具別(使い捨てデバイス、培養液、資本設備)分析、プロシージャタイプ別(フレッシュノンドナー、フローズンノンドナー、フレッシュドナー)分析、最終用途別(不妊治療クリニック、病院、その他の施設)分析、地域別分析、競争分析などの構成でお届けいたします。
・調査目的
・エグゼクティブサマリー
・市場要因・動向・範囲
・体外受精の世界市場:器具別(使い捨てデバイス、培養液、資本設備)
・体外受精の世界市場:プロシージャタイプ別(フレッシュノンドナー、フローズンノンドナー、フレッシュドナー)
・体外受精の世界市場:最終用途別(不妊治療クリニック、病院、その他の施設)
・体外受精の世界市場:地域別
・競争分析
【レポートの概要】

The global in-vitro fertilization market size is expected to reach USD 37.7 billion by 2027, expanding at a CAGR of 9.5%, based on a new report by Grand View Research, Inc. The market is driven by increasing incidence of infertility owing to lifestyle changes, government initiatives to provide better reimbursement policies, and the continuous efforts by the industry contributors. Expansion of fertility procedures for treating male infertility, such as ICSI, is projected to positively influence the growth in near future.

Moreover, the availability of genomic testing enabling the prevention of the transfer of genetic disease during in-vitro fertilization (IVF) use is further expected to drive the IVF market. The increase in the number of IVF treatment has led more insurance players to cover the procedures. This has ultimately led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, which has driven the market with more treatment standardization and automation.

The behavioral shift in the society is the major factor contributing to the decreased Total Fertility Rate (TFR). These factors include an increasing number of women in the labor force, the increased age of the first birth, a shift from rural to urban societies, lower marriage rates, and postponement of marriage.

Obesity is another factor leading to an increase in infertility. The fat deposited on women’s abdomen prevents follicular stimulation and produces male hormones. In case of males, rising fat deposits decrease testosterone levels and can result in lowered sperm production. Doctors recommend weight loss in men prior to fertility treatments along with proper maintenance of Body Mass Index (BMI). The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients.

Further key findings from the study suggest:

• Culture media dominated the overall in-vitro fertilization market in terms of revenue in 2019. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the required media for it, is expected to witness growth

• Moreover, the increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period

• The fresh non-donor segment dominated the IVF market in 2019. According to the 2003 – 2012 trends by the CDC, the number of fresh non-donors banking the eggs/embryos for future use has drastically increased in U.S.

• Europe dominated the procedure and instrument market for in-vitro fertilization in 2019. High quality of treatment offered at the most economical price, and the adherence to medical standards have contributed to its market leadership

• In Europe, the NHS covers three IVF cycles and has also started providing coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America

• North America also accounted for a significant share of the market in 2019. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for market growth in the region

• The presence of favorable reimbursement framework (implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage) is also expected to drive regional market growth over the next six years. The increasing number of clinics undertaking newer techniques to offer better fertility success rates is also expected to increase the demand in the region

• The demand for IVF treatment is expected to boom in APAC owing to fertility tourism and increasing penetration and awareness of the treatment in the developing economies of the region

• The Asia Pacific Initiative on Reproduction (ASPIRE), the task force of clinicians and scientists is involved in the monitoring and management of fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels thereby, driving the market

• Industry contributors are introducing newer automation to shift the IVF treatment from invasive to a minimally invasive or non-invasive procedure. The industry players are also working on technologies, which can enable older women to have enhanced fertility rates

• Some of the key players in the market include EMD Serono Inc.; Boston IVF; OvaScience; Thermo Fisher Scientific Inc.; Vitrolife AB; Irvine Scientific; CooperSurgical, Inc.; Cook Medical Inc.; Genea Biomedx and Progyny Inc.

• In October 2018, Vitrolife entered into a licensing and commercialization agreement with Illumina, Inc. This will provide Vitrolife with exclusive distribution, development, and commercialization rights to Illumina’s preimplantation genetic testing business in Europe, Middle East and Africa, and North America.

【レポートの目次】

Table of Contents

Chapter 1 Research Objectives
1.1 Objective – 1:
1.2 Objective – 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.4 Clinical Trials
3.5 User Perspective Analysis
3.5.1 Consumer Behavior Analysis
3.5.2 Market Influencer Analysis
3.6 Regulatory Framework & Reimbursement Scenario
3.6.1 North America
3.6.2 Europe
3.6.3 Asia Pacific
3.6.4 Latin America
3.6.5 Middle East & Africa
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Rising reprotourism
3.7.1.2 Technological advancements in IVF
3.7.1.3 Favorable government funding
3.7.1.4 Late initiation of family
3.7.1.5 Increasing incidence rate of male and female infertility
3.7.1.6 Mergers and acquisitions (M&A)
3.7.2 Market Restraint Analysis
3.7.2.1 High cost of IVF treatment
3.7.2.2 Lack of regulatory framework and uniform regulations
3.7.3 Porter’s Five Forces Analysis
3.7.3.1 Bargaining power of buyers
3.7.3.2 Bargaining power of suppliers
3.7.3.3 Competitive rivalry
3.7.3.4 Threat of new entrants
3.7.3.5 Threat of substitutes
3.8 Business Environment Analysis Tools
3.8.1 Swot Analysis, By Pestel
3.8.1.1 Political & legal
3.8.1.2 Economic
3.8.1.3 Technological
3.8.2 Major Deals & Strategic Alliances Analysis
3.8.2.1 Joint ventures
3.8.2.2 Mergers & acquisitions
Chapter 4 In-Vitro Fertilization (IVF) Market: Instrument Analysis
4.1 In-Vitro Fertilization (IVF) Market Share Analysis, 2019 & 2027
4.2 Segment Dashboard
4.3 In-Vitro Fertilization (IVF) Market, by Instrument, 2016 to 2027
4.4 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Instrument
4.4.1 Culture Media
4.4.1.1 Culture media market, 2016 – 2027 (USD Million)
4.4.2 Disposable Devices
4.4.2.1 Disposable devices market, 2016 – 2027 (USD Million)
4.4.3 Capital Equipment
4.4.3.1 Capital equipment market, 2016 – 2027 (USD Million)
Chapter 5 In-Vitro Fertilization (IVF) Market: Procedure Type Analysis
5.1 In-Vitro Fertilization (IVF) by Type Market Share Analysis, 2019 & 2027
5.2 Segment Dashboard
5.3 Global IVF Market, by Treatment Type, 2016 – 2027
5.4 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Treatment Type
5.4.1 Fresh Nondonor
5.4.1.1 Fresh nondonor market, 2016 – 2027 (USD Million)
5.4.2 Frozen Nondonor
5.4.2.1 Frozen nondonor market, 2016 – 2027 (USD Million)
5.4.3 Fresh Donor
5.4.3.1 Fresh donor market, 2016 – 2027 (USD Million)
5.4.4 Frozen Donor
5.4.4.1 Frozen donor market, 2016 – 2027 (USD Million)
Chapter 6 In-Vitro Fertilization (IVF) Market: End-use Analysis
6.1 In-Vitro Fertilization (IVF) End-use Market Share Analysis, 2019 & 2027
6.2 Segment Dashboard
6.3 In-Vitro Fertilization (IVF) Market, by End Use, 2016 – 2027
6.4 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Following End Use
6.4.1 Fertility Clinics
6.4.1.1 Fertility clinics market, 2016 – 2027 (USD Million)
6.4.2 Hospitals & Other Settings
6.4.2.1 Hospitals & other settings market, 2016 – 2027 (USD Million)
Chapter 7 Regional Outlook
7.1 Definitions & Scope
7.2 Regional Market Share Analysis, 2019 & 2027
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA
7.6 Market Size, & Forecasts and Trend Analysis, 2019 to 2027
7.6.1 North America
7.6.1.1 North America in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.1.2 U.S.
7.6.1.2.1 U.S. in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.1.3 Canada
7.6.1.3.1 Canada in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2 Europe
7.6.2.1 Europe in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.2 U.K.
7.6.2.2.1 U.K. in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.3 Germany
7.6.2.3.1 Germany in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.4 France
7.6.2.4.1 France in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.5 Italy
7.6.2.5.1 Italy in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.6 Spain
7.6.2.6.1 Spain in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.7 Netherlands
7.6.2.7.1 Netherlands in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.8 Switzerland
7.6.2.8.1 Switzerland in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.2.9 Belgium
7.6.2.9.1 Belgium in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.3 Asia Pacific
7.6.3.1 Asia Pacific in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.3.2 Japan
7.6.3.2.1 Japan in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.3.3 China
7.6.3.3.1 China in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.3.4 India
7.6.3.4.1 India in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.4 Latin America
7.6.4.1 Latin America in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.4.2 Brazil
7.6.4.2.1 Brazil in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.4.3 Mexico
7.6.4.3.1 Mexico in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.5 Middle East And Africa
7.6.5.1 MEA in-vitro fertilization market, 2016 – 2027 (USD Million)
7.6.5.2 South Africa
7.6.5.2.1 South Africa in-vitro fertilization market, 2016 – 2027 (USD Million)
Chapter 8 Competitive Analysis
8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2 Vendor Landscape
8.2.1 Strategy Mapping
8.2.2 Launch Of New Products:
8.2.3 Merger And Acquisition:
8.2.4 Geographical Expansion:
8.2.5 Partnerships:
8.3 Public Companies
8.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
8.4 Private Companies
8.4.1 List Of Key Emerging Companies/Technology
8.4.2 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
8.5 Company Profiles
8.5.1 OVASCIENCE, INC.
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Product benchmarking
8.5.1.4 Strategic initiatives
8.5.1.5 SWOT analysis
8.5.2 VITROLIFE
8.5.2.1 Company overview
8.5.2.2 Financial performance
8.5.2.3 Product benchmarking
8.5.2.4 Strategic initiatives
8.5.2.5 SWOT analysis
8.5.3 EMD SERONO, INC.
8.5.3.1 Company overview
8.5.3.2 Financial performance
8.5.3.3 Product benchmarking
8.5.3.4 Strategic initiatives
8.5.3.5 SWOT analysis
8.5.4 IRVINE SCIENTIFIC
8.5.4.1 Company overview
8.5.4.2 Financial performance
8.5.4.3 Product benchmarking
8.5.4.4 Strategic initiatives
8.5.4.5 SWOT analysis
8.5.5 THE COOPER COMPANIES, INC.
8.5.5.1 Company overview
8.5.5.2 Product benchmarking
8.5.5.3 SWOT analysis
8.5.6 COOK MEDICAL (COOK GROUP)
8.5.6.1 Company overview
8.5.6.2 Product benchmarking
8.5.6.3 Strategic initiatives
8.5.6.4 SWOT analysis
8.5.7 THERMO FISHER SCIENTIFIC, INC.
8.5.7.1 Company overview
8.5.7.2 Financial performance
8.5.7.3 Product benchmarking
8.5.7.4 Strategic initiatives
8.5.7.5 SWOT analysis
8.5.8 GENEA BIOMEDX
8.5.8.1 Company overview
8.5.8.2 Product benchmarking
8.5.8.3 Strategic initiatives
8.5.8.4 SWOT analysis
8.5.9 PROGYNY, INC.
8.5.9.1 Company overview
8.5.9.2 Financial performance
8.5.9.3 Product benchmarking
8.5.9.4 Strategic initiatives
8.5.9.5 SWOT analysis
8.5.10 BOSTON IVF
8.5.10.1 Company overview
8.5.10.2 Financial performance
8.5.10.3 Product benchmarking
8.5.10.4 Strategic initiatives
8.5.10.5 SWOT analysis
8.5.11 ORIGIO
8.5.11.1 Company overview
8.5.11.2 Financial performance
8.5.11.3 Product benchmarking
8.5.11.4 Strategic initiatives
8.5.11.5 SWOT analysis
8.5.12 FERRING PHARMACEUTICAL
8.5.12.1 Company overview
8.5.12.2 Financial performance
8.5.12.3 Product benchmarking
8.5.12.4 Strategic initiatives
8.5.12.5 SWOT analysis
8.5.13 BAYER AG
8.5.13.1 Company overview
8.5.13.2 Financial performance
8.5.13.3 Product benchmarking
8.5.13.4 Strategic initiatives
8.5.13.5 SWOT analysis
8.5.14 MERCK & CO., INC.
8.5.14.1 Company overview
8.5.14.2 Financial performance
8.5.14.3 Product benchmarking
8.5.14.4 Strategic initiatives
8.5.14.5 SWOT analysis
8.5.15 ORGANON
8.5.15.1 Company overview
8.5.15.2 Financial performance
8.5.15.3 Product benchmarking
8.5.15.4 Strategic initiatives
8.5.15.5 SWOT analysis
Chapter 9 KOL Commentary & Recommendations
Chapter 10 Research Methodology & Scope
10.1 Research Methodology
10.1.1 Information procurement
10.1.1.1 Purchased database:
10.1.1.2 GVR’s internal database
10.1.2 Primary research:
10.2 Research Scope and Assumptions
10.3 List to Data Sources
Chapter 11 Report FAQs
11.1 How Do I Trust Your Report Quality/Data Accuracy?
11.2 My Research Requirement Is Very Specific; Can I Customize This Report?
11.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
11.4 How Do You Arrive At These Market Numbers?
11.5 Who Are Your Clients?
11.6 How Will I Receive This Report?
Chapter 12 Appendix
Chapter 13 Compass – Cloud Based Report Delivery Platform
Chapter 14 Related Reports

List of Tables

TABLE 1 E-cigarette and vape market - Industry snapshot & key buying criteria, 2016 - 2027
TABLE 2 E-cigarette and vape market, 2016 - 2027 (USD Million, Million Units)
TABLE 3 E-cigarette and vape market, by region, 2016 - 2027 (USD Million)
TABLE 4 E-cigarette and vape market, by region, 2016 - 2027 (Million Units)
TABLE 5 E-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 6 E-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 7 E-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 8 E-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 9 E-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 10 E-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 11 Vendor landscape
TABLE 12 E-cigarette and vape - Key market driver impact
TABLE 13 E-cigarette and vape - Key market restraint impact
TABLE 14 British American Tobacco product price
TABLE 15 Imperial Brands product price
TABLE 16 Disposable e-cigarettes market, 2016 - 2027 (USD Million, Million Units)
TABLE 17 Disposable e-cigarettes market, by region, 2016 - 2027 (USD Million)
TABLE 18 Disposable e-cigarettes market, by region, 2016 - 2027 (Million Units)
TABLE 19 Rechargeable e-cigarettes market, 2016 - 2027 (USD Million, Million Units)
TABLE 20 Rechargeable e-cigarettes market, by region, 2016 - 2027 (USD Million)
TABLE 21 Rechargeable e-cigarettes market, by region, 2016 - 2027 (Million Units)
TABLE 22 Modular devices market, 2016 - 2027 (USD Million, Million Units)
TABLE 23 Modular devices market, by region, 2016 - 2027 (USD Million)
TABLE 24 Modular devices market, by region, 2016 - 2027 (Million Units)
TABLE 25 Atomizer market, 2016 - 2027 (USD Million, Million Units)
TABLE 26 Atomizer market, by region, 2016 - 2027 (USD Million)
TABLE 27 Atomizer market, by region, 2016 - 2027 (Million Units)
TABLE 28 Vape mod market, 2016 - 2027 (USD Million, Million Units)
TABLE 29 Vape mod market, by region, 2016 - 2027 (USD Million)
TABLE 30 Vape mod market, by region, 2016 - 2027 (Million Units)
TABLE 31 Cartomizer market, 2016 - 2027 (USD Million, Million units)
TABLE 32 Cartomizer market, by region, 2016 - 2027 (USD Million)
TABLE 33 Cartomizer market, by region, 2016 - 2027 (Million Units)
TABLE 34 E-liquid market, 2016 - 2027 (USD Million, Million Units)
TABLE 35 E-liquid market, by region, 2016 - 2027 (USD Million)
TABLE 36 E-liquid market, by region, 2016 - 2027 (Million Units)
TABLE 37 Online market, 2016 - 2027 (USD Million)
TABLE 38 Online market, by region, 2016 - 2027 (USD Million)
TABLE 39 Retail store market, 2016 - 2027 (USD Million)
TABLE 40 Retail store market, by region, 2016 - 2027 (USD Million)
TABLE 41 Convenience store market, 2016 - 2027 (USD Million)
TABLE 42 Convenience store market, by region, 2016 - 2027 (USD Million)
TABLE 43 Drug store market, 2016 - 2027 (USD Million)
TABLE 44 Drug store market, by region, 2016 - 2027 (USD Million)
TABLE 45 Newsstand market, 2016 - 2027 (USD Million)
TABLE 46 Newsstand market, by region, 2016 - 2027 (USD Million)
TABLE 47 Tobacconist store market, 2016 - 2027 (USD Million)
TABLE 48 Tobacconist store market, by region, 2016 - 2027 (USD Million)
TABLE 49 Specialty e-cigarette store market, 2016 - 2027 (USD Million)
TABLE 50 Specialty e-cigarette store market, by region, 2016 - 2027 (USD Million)
TABLE 51 North America e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 52 North America e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 53 North America e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 54 North America e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 55 North America e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 56 North America e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 57 North America e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 58 U.S. e-cigarette and vape market, 2016 - 2027 (USD Million, Million Units)
TABLE 59 U.S. e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 60 U.S. e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 61 U.S. e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 62 U.S. e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 63 U.S. e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 64 U.S. e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 65 Canada e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 66 Canada e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 67 Canada e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 68 Canada e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 69 Canada e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 70 Canada e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 71 Canada e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 72 Europe e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 73 Europe e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 74 Europe e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 75 Europe e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 76 Europe e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 77 Europe e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 78 Europe e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 79 U.K. e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 80 U.K. e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 81 U.K. e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 82 U.K. e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 83 U.K. e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 84 U.K. e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 85 U.K. e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 86 Germany e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 87 Germany e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 88 Germany e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 89 Germany e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 90 Germany e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 91 Germany e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 92 Germany e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 93 Asia Pacific e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 94 Asia Pacific e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 95 Asia Pacific e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 96 Asia Pacific e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 97 Asia Pacific e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 98 Asia Pacific e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 99 Asia Pacific e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 100 China e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 101 China e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 102 China e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 103 China e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 104 China e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 105 China e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 106 China e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 107 South Korea e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 108 South Korea e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 109 South Korea e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 110 South Korea e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 111 South Korea e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 112 South Korea e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 113 South Korea e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 114 Japan e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 115 Japan e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 116 Japan e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 117 Japan e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 118 Japan e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 119 Japan e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 120 Japan e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 121 Latin America e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 122 Latin America e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 123 Latin America e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 124 Latin America e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 125 Latin America e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 126 Latin America e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 127 Latin America e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 128 Brazil e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 129 Brazil e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 130 Brazil e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 131 Brazil e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 132 Brazil e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 133 Brazil e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 134 Brazil e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)
TABLE 135 MEA e-cigarette and vape market, 2016 - 2027 (USD Million)
TABLE 136 MEA e-cigarette and vape market, by product, 2016 - 2027 (USD Million)
TABLE 137 MEA e-cigarette and vape market, by product, 2016 - 2027 (Million Units)
TABLE 138 MEA e-cigarette and vape market, by component, 2016 - 2027 (USD Million)
TABLE 139 MEA e-cigarette and vape market, by component, 2016 - 2027 (Million Units)
TABLE 140 MEA e-cigarette and vape market, by distribution channel, 2016 - 2027 (USD Million)
TABLE 141 MEA e-cigarette and vape market, by retail store, 2016 - 2027 (USD Million)

List of Figures

FIG. 1 Market segmentation and scope
FIG. 2 E-cigarette and vape market, 2014 - 2025 (USD Million)
FIG. 3 E-cigarette and vape - Value chain analysis
FIG. 4 E-cigarette and vape market dynamics
FIG. 5 Coil temperature on temperature control vs variable wattage, (in Fahrenheit)
FIG. 6 Adult population perception of harm from e-cigarettes compared to smoking, 2016 (percentage)
FIG. 7 E-cigarette and vape - Company market share analysis, 2018
FIG. 8 U.S. E-cigarette - Company market share analysis, 2018
FIG. 9 Key opportunities prioritized
FIG. 10 E-cigarette and vape market - Porter’s five forces analysis
FIG. 11 E-cigarette and vape market - PESTEL analysis
FIG. 12 E-cigarette and vape market, by type, 2018 & 2025
FIG. 13 E-cigarette and vape market, by component, 2018 & 2025
FIG. 14 E-cigarette and vape market, by distribution channel, 2018 & 2025
FIG. 15 E-cigarette and Vape market by region, 2018 & 2025
FIG. 16 Regional market place - Key takeaways
FIG. 17 North America e-cigarette and vape market - Key takeaways
FIG. 18 Europe e-cigarette and vape market - Key takeaways
FIG. 19 Asia Pacific e-cigarette and vape market - Key takeaways
FIG. 20 Latin America e-cigarette and vape market - Key takeaways
FIG. 21 MEA e-cigarette and vape market - Key takeaways

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[体外受精の世界市場:器具別(使い捨てデバイス、培養液、資本設備)、プロシージャタイプ別、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆